Enterprise solution
Stroke care
Philips is committed to strengthening stroke care, helping to build a system that better serves patients across their entire care experience. This includes not only developing the right solutions, but also driving advocacy for better access to stroke care globally.
Shaping the future of stroke care to improve the lives of millions
Acute ischemic stroke is the second leading cause of mortality and a key cause of long-term disability worldwide[1]. Philips is a technology leader committed to strengthening stroke care, helping to build a system that better serves patients across their entire care experience. This includes not only developing the right solutions but also driving advocacy for better access to stroke care globally. Together, we can expand access and create a better care pathway that speeds up diagnostic decisions, improving stroke care and patient outcomes to make a difference for stroke patients worldwide.
Driving improved access to stroke care around the world
- Endovascular stroke treatment revolutionized stroke management in 2015, changing the outlook for stroke patients with its ability to save millions from life-long disability
- Philips offers solutions to transform stroke care, but currently <5% of stroke patients receive adequate treatment[2]
- Improving access to care requires global investments in healthcare infrastructure and the specialist workforce
- Philips seeks to lead stroke care change, working with organizations to inform and educate government and policymakers on the potential impact of stroke care investment
Innovations that make a difference in the stroke care pathway
- Advanced imaging of Verdia Spectral CT and SmartSpeed Precise, and the alerts of Nicolab StrokeViewer[3]* help speed time to treatment
- Azurion with SmartCT drives fast, decisive treatment of stroke patients day and night
- ePatch** for proactive, early detection of Afib
Speed is key in delivering time-sensitive, life-saving care in stroke
- Philips CT and MR systems offer fast exams with exceptional image quality for diagnostic confidence
- In stroke, time is brain and Azurion neuro suite features a 12% reduction in in-lab preparation time supported by ProcedureCards[4]
- Integration of Nicolab StrokeViewer into workflows reduces the number of undetected large vessel occlusions (LVOs) by 20%[5] and door-to-groin puncture time by 17%[6]
- ePatch offers up to 14 days of ambulatory ECG recording to support earlier detection of atrial fibrillation after stroke.
Why a better care pathway for stroke is essential and what Philips is doing to help
- Every 2 seconds someone in the world is affected by stroke[7], 40% of stroke patients arrive too late for basic stroke treatment[8] and <5% of stroke patients receive adequate treatment[2]
- Complexity adds time to stroke patient management and a network of separate, yet highly interdependent, workflows must work fluidly together
- Gaps in information, communication and access to expertise can cause delays, with tragic consequences for stroke patients
- Philips is committed to strengthening the stroke care system, helping to build a system that better serves patients across the care journey
Demonstrated results in stroke care
109%
faster reconstruction time [9]
When every decision depends on timely insight, faster access to spectral results matters. Verida Spectral CT helps you move from acquisition to reading faster with 109% faster reconstruction time of spectral results.[9]
Read more20%
reduction in initially undetected LVOs [5]
Interact with StrokeViewer from Azurion at tableside without breaking sterility to streamline stroke workflows. Use of StrokeViewer reduces initially undetected LVOs by 20%[5], which potentially increases the number of patients treated with endovascular thrombectomy (EVT).
Download12%
less preparation time [10]
When you need to treat fast, simpler preparation can help save valuable time. Azurion with SmartCT helps teams set up the cath lab for a stroke intervention in one tap with ProcedureCards – supporting a 12% reduction in in-lab preparation time at St. Antonius Hospital. [10]
Read more4 times
greater Atrial fibrillation (AF) detection [11]
Atrial fibrillation (AF) is a key risk factor for stroke. Philips ePatch [12] extended Holter provides up to 14 days [13] of recording that is simple, actionable and efficient. Compared with 24 hour traditional Holter, 14 day ePatch extended Holter demonstrates 4 times greater AF detection. [11]
Read more
Philips supports collaborative stroke care
See how Philips can help you save critical time to help improve stroke patient outcomes, from emergency care to fast diagnosis and confident treatment to post-stroke patient care.
Portfolio highlights
1/3
Frequently asked questions
Documentation
Footnotes
- www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
- Saini V, et al. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97:S6-S16
- StrokeViewer is a trademark of Nicolab.
- The results achieved in this first Azurion lab performance study (2017) have been verified by an independent third party. Results are specific to the institution where they were obtained (St. Antonius hospital, Nieuwegein, The Netherlands) and may not reflect the results achievable at other institutions.
- Fasen, et al. Neuroradiology. 2022.
- Multicenter Innovate study across a leading Hub and Spoke network in The Netherlands in 2020, data collection ongoing. Streamlined stroke workflow | StrokeViewer | Nicolab
- Lindsay P, et al. World Stroke Organization global stroke services guidelines and action plan. Int J Stroke. 2014 Oct;9 Suppl A100:4-13
- Saver JL, et al. The “golden hour” and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010 Jul;41(7):1431-9.
- Based on in-house phantom testing under reference body protocol conditions
- Data on file. The results have been verified by an independent third party. Results are specific to the institution where they were obtained, St. Antonius Hospital, Nieuwegein, The Netherlands, and may not reflect results achievable at other institutions.
- As presented at ACC Scientific Sessions 2023; Diagnostic Yield of 24-Hour Holter vs 7-Day and 14-Day ePatch Extended Wear Holter; Parikh et al.
- Requena M, Vanden Bavière H, Verma S, et al. Cost-utility of direct transfer to angiography suite (DTAS) bypassing conventional imaging for patients with acute ischemic stroke in Spain: results from the ANGIOCAT trial. Journal of NeuroInterventional Surgery Published Online First: 27 April 2023. doi: 10.1136/jnis-2023-020275
Disclaimer
*This solution is not available in all countries. Consult your local Philips representative for more detailed information.
**Philips ePatch® is a Class IIa medical device and validated as an Ambulatory ECG device (Holter) using the Harmonized Standard ISO60601-2-47 and developed using EN13485 as a quality management system. Diagnostic options vary by markets.